Several Companies

 
News Articles for Several Companies top ^
Dupilumab Demonstrated Improvement in Lung Function, Reductions of Severe Exacerbations TARRYTOWN, N.Y. and PARIS , Nov.
Sign-up for Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma investment picks
FIRST OF SEVERAL PHASE 3 TRIALS TO REPORT RESULTS INDIANAPOLIS , Dec.
Sign-up for Lilly and Incyte Announce Positive Top-Line Results From Phase 3 Trial of Baricitinib in Moderate to Severe Rheumatoid Arthritis investment picks
Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain Canada NewsWire DUBLIN and RALEIGH, N.C. , Dec.
Sign-up for Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain investment picks
2014/11/14
ECA Group, subsidiary of Groupe Gorgé, has just won a major contract to supply naval simulators to the Navy of an Asian country.
Sign-up for Groupe Gorgé Announces the Sale of Several Naval Simulators to a Major Asian Navy investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc reported the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorization for Revolade™ (eltrombopag), seeking an additional indication for the treatment of adult patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). SAA is a rare disorder in which the bone marrow fails to make enough new blood cells.
Sign-up for Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade™ (eltrombopag) investment picks
Brodalumab Meets All Primary and All Key Secondary Endpoints Meets Primary Endpoint of Superiority to Stelara® (ustekinumab) in Achieving Total Skin Clearance (PASI 100) Meets Co-Primary Endpoints Against Placebo THOUSAND OAKS, Calif.
Sign-up for Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis investment picks
Study Met All Primary Endpoints Against Stelara® (ustekinumab) and Placebo Three Pivotal Studies Form the Basis for Global Regulatory Filings, Planned In 2015 THOUSAND OAKS, Calif.
Sign-up for Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis investment picks
Pioneer Natural Resources Company (NYSE:PXD) (“Pioneer” or “the Company”) today announced that severe winter weather in West Texas has significantly impacted production and drilling operations in the Spraberry/Wolfcamp area.
Sign-up for Pioneer Natural Resources Announces That Severe Winter Weather Has Impacted Production and Drilling Operations in West Texas investment picks
2015/1/6
By Tess Stynes Walgreen Boots Alliance Inc. said December sales, excluding newly opened or closed locations, rose 9.2%, benefiting from a calendar shift and an early start to what is expected to be a severe flu season.
Sign-up for Walgreen Sales Surge in December on More Severe Flu Season investment picks
2014/12/16
Nuveen Investments, a leading global provider of investment services to institutions as well as individual investors, today announced that several closed-end funds have declared additional cash distributions with the record, ex-dividend and payable date mentioned below.
Sign-up for Several Nuveen Closed-End Funds Declare Capital Gains investment picks
2014/10/27
CHARLOTTE, N.C. , Oct.
Sign-up for Newest Virginia-class submarine commissioned bears several systems from UTC Aerospace Systems investment picks
FORT WORTH, Texas , Nov.
Sign-up for Basic Energy Services To Present At Several Investor Conferences During November investment picks
2014/11/7
By Michael Calia Sprint Corp.
Sign-up for Sprint to take additional $105 million charge on severance costs investment picks
CAMARILLO, Calif.
Sign-up for Salem Communications Announces Structure Changes and Several Internal Promotions investment picks
2014/11/12
Nuveen Investments, a leading global provider of investment services to institutions, as well as individual investors, today announced that seven closed-end funds have declared additional cash distributions with the record, ex-dividend and payable date outlined below.
Sign-up for Several Nuveen Closed-End Funds Declare Capital Gains investment picks
New Software Helps Customers Manage their App Experience AUSTIN, Texas and NEW YORK , Nov.
Sign-up for Digital Turbine Ignite Now Available on Several Smartphones from Verizon Wireless investment picks
2014/12/1
Nuveen Investments, a leading global provider of investment services to institutions, as well as individual investors, today announced that 42 closed-end funds have declared additional cash distributions with the record, ex-dividend, payable and reinvest date outlined below.
Sign-up for Several Nuveen Closed-End Funds Declare Year-End Distributions investment picks
2014/12/1
ROCKVILLE, Md., Dec.
Sign-up for Seven-day event brings together severely injured service members and their families from across the country investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Several Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Seven Companies  |  Next: Shale Assets